Cargando…
Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region
AIMS/INTRODUCTION: This study determined the prevalence and risk factors for diabetic peripheral neuropathy (DPN), painful DPN and diabetic foot ulceration (DFU) in patients with type 2 diabetes in secondary healthcare in Qatar, Kuwait and the Kingdom of Saudi Arabia. MATERIALS AND METHODS: Adults a...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434582/ https://www.ncbi.nlm.nih.gov/pubmed/35445568 http://dx.doi.org/10.1111/jdi.13815 |
_version_ | 1784780904958263296 |
---|---|
author | Ponirakis, Georgios Elhadd, Tarik Al Ozairi, Ebaa Brema, Imad Chinnaiyan, Subitha Taghadom, Etab Al Kandari, Jumana Al Wotayan, Rehab Al Ozairi, Abdulla Aljohani, Naji AlMistehi, Wael Al Qahtani, Nora Khan, Shawana Dabbous, Zeinab Siddique, Mashhood A Petropoulos, Ioannis N Khan, Adnan Almuhannadi, Hamad Ashawesh, Khaled AE Dukhan, Khaled M Mahfoud, Ziyad R Zirie, Mahmoud A Jayyousi, Amin Malik, Rayaz A |
author_facet | Ponirakis, Georgios Elhadd, Tarik Al Ozairi, Ebaa Brema, Imad Chinnaiyan, Subitha Taghadom, Etab Al Kandari, Jumana Al Wotayan, Rehab Al Ozairi, Abdulla Aljohani, Naji AlMistehi, Wael Al Qahtani, Nora Khan, Shawana Dabbous, Zeinab Siddique, Mashhood A Petropoulos, Ioannis N Khan, Adnan Almuhannadi, Hamad Ashawesh, Khaled AE Dukhan, Khaled M Mahfoud, Ziyad R Zirie, Mahmoud A Jayyousi, Amin Malik, Rayaz A |
author_sort | Ponirakis, Georgios |
collection | PubMed |
description | AIMS/INTRODUCTION: This study determined the prevalence and risk factors for diabetic peripheral neuropathy (DPN), painful DPN and diabetic foot ulceration (DFU) in patients with type 2 diabetes in secondary healthcare in Qatar, Kuwait and the Kingdom of Saudi Arabia. MATERIALS AND METHODS: Adults aged 18–85 years with type 2 diabetes were randomly enrolled from secondary healthcare, and underwent clinical and metabolic assessment. DPN was evaluated using vibration perception threshold and neuropathic symptoms and painful Diabetic Peripheral Neuropathy was evaluated using the Douleur Neuropathique 4 questionnaire. RESULTS: A total of 3,021 individuals were recruited between June 2017 and May 2019. The prevalence of DPN was 33.3%, of whom 52.2% were at risk of DFU and 53.6% were undiagnosed. The prevalence of painful DPN was 43.3%, of whom 54.3% were undiagnosed. DFU was present in 2.9%. The adjusted odds ratios for DPN and painful DPN were higher with increasing diabetes duration, obesity, poor glycemic control and hyperlipidemia, and lower with greater physical activity. The adjusted odds ratio for DFU was higher with the presence of DPN, severe loss of vibration perception, hypertension and vitamin D deficiency. CONCLUSIONS: This is the largest study to date from the Middle East showing a high prevalence of undiagnosed DPN, painful DPN and those at risk of DFU in patients with type 2 diabetes, and identifies their respective risk factors. |
format | Online Article Text |
id | pubmed-9434582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94345822022-09-08 Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region Ponirakis, Georgios Elhadd, Tarik Al Ozairi, Ebaa Brema, Imad Chinnaiyan, Subitha Taghadom, Etab Al Kandari, Jumana Al Wotayan, Rehab Al Ozairi, Abdulla Aljohani, Naji AlMistehi, Wael Al Qahtani, Nora Khan, Shawana Dabbous, Zeinab Siddique, Mashhood A Petropoulos, Ioannis N Khan, Adnan Almuhannadi, Hamad Ashawesh, Khaled AE Dukhan, Khaled M Mahfoud, Ziyad R Zirie, Mahmoud A Jayyousi, Amin Malik, Rayaz A J Diabetes Investig Articles AIMS/INTRODUCTION: This study determined the prevalence and risk factors for diabetic peripheral neuropathy (DPN), painful DPN and diabetic foot ulceration (DFU) in patients with type 2 diabetes in secondary healthcare in Qatar, Kuwait and the Kingdom of Saudi Arabia. MATERIALS AND METHODS: Adults aged 18–85 years with type 2 diabetes were randomly enrolled from secondary healthcare, and underwent clinical and metabolic assessment. DPN was evaluated using vibration perception threshold and neuropathic symptoms and painful Diabetic Peripheral Neuropathy was evaluated using the Douleur Neuropathique 4 questionnaire. RESULTS: A total of 3,021 individuals were recruited between June 2017 and May 2019. The prevalence of DPN was 33.3%, of whom 52.2% were at risk of DFU and 53.6% were undiagnosed. The prevalence of painful DPN was 43.3%, of whom 54.3% were undiagnosed. DFU was present in 2.9%. The adjusted odds ratios for DPN and painful DPN were higher with increasing diabetes duration, obesity, poor glycemic control and hyperlipidemia, and lower with greater physical activity. The adjusted odds ratio for DFU was higher with the presence of DPN, severe loss of vibration perception, hypertension and vitamin D deficiency. CONCLUSIONS: This is the largest study to date from the Middle East showing a high prevalence of undiagnosed DPN, painful DPN and those at risk of DFU in patients with type 2 diabetes, and identifies their respective risk factors. John Wiley and Sons Inc. 2022-05-05 2022-09 /pmc/articles/PMC9434582/ /pubmed/35445568 http://dx.doi.org/10.1111/jdi.13815 Text en © 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Articles Ponirakis, Georgios Elhadd, Tarik Al Ozairi, Ebaa Brema, Imad Chinnaiyan, Subitha Taghadom, Etab Al Kandari, Jumana Al Wotayan, Rehab Al Ozairi, Abdulla Aljohani, Naji AlMistehi, Wael Al Qahtani, Nora Khan, Shawana Dabbous, Zeinab Siddique, Mashhood A Petropoulos, Ioannis N Khan, Adnan Almuhannadi, Hamad Ashawesh, Khaled AE Dukhan, Khaled M Mahfoud, Ziyad R Zirie, Mahmoud A Jayyousi, Amin Malik, Rayaz A Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region |
title | Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region |
title_full | Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region |
title_fullStr | Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region |
title_full_unstemmed | Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region |
title_short | Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region |
title_sort | prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the arabian gulf region |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434582/ https://www.ncbi.nlm.nih.gov/pubmed/35445568 http://dx.doi.org/10.1111/jdi.13815 |
work_keys_str_mv | AT ponirakisgeorgios prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT elhaddtarik prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT alozairiebaa prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT bremaimad prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT chinnaiyansubitha prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT taghadometab prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT alkandarijumana prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT alwotayanrehab prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT alozairiabdulla prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT aljohaninaji prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT almistehiwael prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT alqahtaninora prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT khanshawana prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT dabbouszeinab prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT siddiquemashhooda prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT petropoulosioannisn prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT khanadnan prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT almuhannadihamad prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT ashaweshkhaledae prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT dukhankhaledm prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT mahfoudziyadr prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT ziriemahmouda prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT jayyousiamin prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion AT malikrayaza prevalenceandriskfactorsfordiabeticperipheralneuropathyneuropathicpainandfootulcerationinthearabiangulfregion |